Action Date News Today

PDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and...

The Department of State released the April 2024 Visa Bulletin. USCIS will continue to accept employment-based Adjustment of Status applications based on the Final Action Dates chart....

The Department of State released the March 2024 Visa Bulletin. In March, USCIS will accept employment-based Adjustment of Status applications based on the more modest Final Action Dates...

The Department of State released the February 2024 Visa Bulletin. All Employment-Based Categories will hold steady for February under Dates for Filing with minor advancement for EB-2...

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Companys...

US FDA accepted NDA filing for ensifentrine for maintenance treatment of COPD PDUFA Target Action Date of June 26, 2024 Commercial launch preparations supported by strong balance sheet Conference...

PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support potential of ensifentrine, an investigational, novel, selective, dual inhibitor of PDE3 and PDE4 LONDON...

Label Expansion Decisions Expected from U.S. and European Regulatory Authorities in Q4 SAN RAFAEL, Calif., Sept. 21, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. , a global biotechnology...

BioMarin Pharmaceutical Inc. announced that new data on VOXZOGO®? in children with achondroplasia will be presented at the 61st Annual European Society for Paediatric Endocrinology Meeting in The...

(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) announced the European Medicines Agencys Committee for Medicinal Products for Human Use has adopt...